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Abstract
Skin-derived precursors (SKPs) are defined as multipotent spheroid-forming cells
cultured from the dermis that express markers of neural crest origin. Recent evidence
suggests that tissue fibrosis can occur through the differentiation of progenitor cells into
smooth muscle-like myofibroblasts. CCN2, a marker and mediator of fibrosis, is highly
expressed during myofibroblast differentiation and is required for skin fibrogenesis. Here,
I clarify the cellular origin of SKPs, and the molecular contribution of CCN2 in the
myofibroblastic differentiation of SKPs. Using lineage tracing, I show that SKPs
originate primarily from Col1a2-expressing dermal fibroblasts. Furthermore, I show that
differentiation of SKPs into myofibroblasts requires the FAK and SRF-mediated
induction of CCN2: Col1a2-specific deletion of CCN2 impairs the ability of SKPs to
differentiate into α-SMA-expressing myofibroblasts. Taken together, these results
suggest that collagen-producing fibroblasts possess inherent plasticity, and that CCN2 is
a downstream mediator of the ability of SKPs to differentiate into myofibroblasts.
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Introduction
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1.1

Overview of Skin-derived Precursors

Skin-derived precursors (SKPs) are multipotent spheroid-forming cells that can be
cultured from dermal tissue (Biernaskie et al., 2009). Traditionally grown from
dissociated dermal cells cultured in media containing both epidermal grown factor (EGF)
and basic fibroblast growth factor (bFGF), SKPs express neural progenitor cell markers
such as Nestin and Sox2, and are capable of self-renewal and differentiation into neural,
glial and mesodermal lineages (Fernandes and Miller, 2009; Kang et al., 2011). This
differentiation potential, coupled with relative ease of access in the skin has made SKPs
an intriguing source of cells for cell replacement therapies and tissue-engineering (Chen
at al., 2012). However, it is contentious whether SKPs represent an endogenous precursor
cell population within the dermis or whether they are a result of culture-induced
dedifferentiation of resident mesenchymal cells (Fernandes et al., 2008).

1.1.1 SKPs: A Brief History
By the year 2000, it had been reported that adult stem cells, defined by their
capability to self-renew and differentiate into multiple cell types, could be isolated from
several sources of mammalian tissue including the central nervous system, bone marrow,
retina and skeletal muscle (Prokcop, 1997; Jackson et al., 1999; Gage, 2000; Tropepe et
al., 2000). These adult progenitors were mostly found to be biased to generate
differentiated cells of the same lineage; i.e. neural stem cells into neurons and glial cells,
bone marrow-derived mesenchymal stem cells into mesodermal cells and hematopoetic
stem cells into blood cells. However, transplantation studies had also shown that at least a
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fraction of these cells had the potential to differentiate into cells outside of their lineage
as well. For instance, neural stem cells cultured in vitro and subsequently transplanted
into blastocysts could contribute to all of the germ layers in embryonic tissues, while
transplanted bone marrow stem cells could contribute to brain, liver and skeletal muscle
tissue while expressing tissue-specific markers (Clarke et al. 2000; Ferrari et al., 1998;
Petersen et al., 1999; Mezey et al., 2000). Since using adult tissues bypasses the ethical
issues posed by the use of embryonic stem cells, and can also allow for autologous
transplantation, the potential of adult stem cells for cell replacement therapies was
immediately recognized.
Neural stem cells were particularly promising for the treatment of spinal cord
injuries, as neural progenitors generated from embryonic stem cells had been found to
promote recovery in the injured nervous system (Brustle et al., 1999). However, the only
accessible source for human neural stem cells at that time was from fetal tissue
(Bjorklund et al., 2000). Thus, it was a landmark discovery in 2001 when Miller and
coworkers found that adult dermal tissue could be cultured to generate self-renewing
cells, coined “skin-derived precursors” (SKPs) that could be differentiated into neurons,
glial cells, adipocytes and smooth muscle cells (Toma et al., 2001). Indeed, it was
subsequently shown that transplanted schwann cells generated from SKPs were capable
of promoting functional recovery in a rat model of spinal cord injury, suggesting that
SKPs were viable as an accessible source of neural progenitor cells (Biernaskie et al.,
2007). Due to the unique differentiation potential of SKPs, it was hypothesized that these
cells represented a population of endogenous adult dermal precursors similar to
embryonic neural crest cells.
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1.1.2 SKPs exhibit properties of neural crest cells
The embryonic neural crest is a transient, migratory population of precursor cells
that originates at the dorsal tip of the developing neural tube (Shakova and Sommer,
2008). As neural crest cells migrate from the neural tube, they interact with their
microenvironment to differentiate into a variety of cell types including peripheral
neurons, schwann cells, vascular smooth muscle cells, melanocytes, adipocytes and
connective tissue cells (Biernaskie, 2010). Neural crest derivatives give rise to most of
the peripheral nervous system and are present in adult cardiovascular tissue, craniofacial
bones, cartilage and skin. Furthermore, at least some neural crest-derived cells in adult
tissues retain their capacity for self-renewal and differentiation, and are referred to as
neural crest-derived progenitor cells (NCPCs) (Shakova and Sommer, 2008).
Intriguingly, SKPs were demonstrated to be capable of differentiating into neural crestderivative cell types and were found to express neural crest-associated genes such as
Slug, Snail, Twist, Pax3 and Sox9 (Fernandes et al., 2004). In adult skin, these genes
were exclusively expressed in the hair follicle dermal papilla (DP), which made the DP a
prime candidate for the niche from which SKPs are derived (Fernandes et al., 2004).
Paradoxically however, even though hair follicle DP cells from murine trunk skin
expressed neural crest markers, lineage tracing studies revealed that these cells were not
in fact derived from the neural crest. In contrast, it was found that the neural crest gave
rise to both hair follicle DP and dermal fibroblasts in facial skin (Fernandes et al., 2004).
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1.1.3 Origin of SKPs: The Controversy
The skin is a complex and regenerative tissue thought to contain several
endogenous precursor cell populations including melanocytic stem cells, blood vesselassociated hematopoietic and endothelial precursors as well as epidermal and
mesenchymal stem cells (Fernandes et al., 2008). Particularly, the hair follicle DP
consists of a population of Sox2-expressing precursor cells that can control hair follicle
growth, can migrate and contribute to wound repair, and can differentiate into adipocytes,
osteoblasts, smooth muscle cells, and neurons in vitro (Clavel et al., 2012; Johnston et al.,
2013; Driskell et al., 2011). Building upon their previous finding that SKPs and DP cells
express similar markers, it was proposed by Miller and coworkers in 2009 that Sox-2
expressing DP cells represent a major endogenous niche for SKPs cultured from murine
trunk skin (Biernaskie et al., 2009). This was concluded on the basis that bulk cultured
SKPs and SKPs cultured from Sox2-GFP sorted dermal cells exhibited a similar genomewide expression profile, and that transplanted SKPs could home to a DP niche and induce
hair follicle formation (Biernaskie et al., 2009). However, previous evidence suggested
SKP spheroids could also be cultured from non-follicular skin, indicating that the skin
contains other cell populations outside of the hair follicle can give rise to SKPs (Toma et
al., 2005). Furthermore, it has subsequently been shown that monolayer non-follicular
dermal cultures can be detached and reseeded in SKP growth medium to form SKPs (Hill
et al., 2012). Most recently, a study using lineage tracing analysis suggested that dermal
cells of embryonic mesenchymal origin give rise to SKPs cultured from murine trunk
skin (Krause et al., 2014). However, in spite of all these observations, it remains unclear
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what adult cell type cultured SKPs are derived from, and whether they are derived from
an endogenous Sox2-expressing cell population.

1.1.4 A Case for the Fibroblast
Fibroblasts, the most common cell type found in connective tissue, are
characterized by their ability to produce extracellular matrix components including type I
collagen. In the last decade, numerous studies have been published suggesting that
fibroblasts can be reprogrammed into induced pluripotent stem cells with a cocktail of
transcription factors (i.e. Oct4, Sox2, c-Myc and Klf-4) (Yamanaka, 2012). Intriguingly,
fibroblasts can be directly reprogrammed into neural stem cells by overexpression of
Sox2 alone (Ring et al., 2012). Moreover, it has also been shown that the embryonic
NIH/3T3 fibroblast cell line can be cultured as neurospheres with neuronal differentiation
potential without the addition of any epigenetic modifier (Wang et al., 2011). Thus,
fibroblasts can be readily induced to be stem cell-like. Indeed, it is a point of controversy
whether fibroblasts and mesenchymal stem cells can be considered to be the same cell
type (Junker et al., 2010).
Mesenchymal stem cells, also known as mesenchymal stromal cells or
multipotent stromal cells (MSCs) are plastic adherent cells with fibroblastic morphology
characterized by their ability to differentiate into mesodermal tissues such as bone,
cartilage and fat (Dominici et al., 2006). MSCs have been reported to suppress immune
responses both in vitro and in vivo and have been used in clinical trials to treat graft
versus host disease with success (Le Blanc et al., 2004). Originally isolated from the bone
marrow, MSC-like cells have been cultured from various tissues including skin, muscle,

7

placenta, cord blood, adipose tissue and more (da Silva Meirelles et al., 2006). However,
both the mesodermal differentiation potential and immune suppressing properties of
MSCs have previously been reported for fibroblasts (Lysy et al., 2007; Korn et al., 1981).
Furthermore, the markers currently defined for MSCs (positive for CD73, CD105 and
negative for the hematopoietic markers CD14, CD34 and CD45) are shared by fibroblasts
as well (Haniffa et al., 2009). As it stands, it is unclear whether there are distinct
boundaries between the identity of fibroblasts and MSCs. Taken together, the fibroblast
represents a cell type that may currently be underappreciated for its plasticity, and has not
been thoroughly investigated as a potential origin of cultured SKPs.

1.1.5 SKPs as a model for disease
Regardless of their cellular origin, the fact that SKPs exhibit transcriptional and
functional properties of neural crest precursors makes them an intriguing model to study
diseases thought to be caused by NCPCs in vivo. For instance, SKPs have been used to
study the origin of neurofibromas, which are complex tumours involving the uncontrolled
proliferation of supporting cells around nerve fibers (Le at al., 2009). It was demonstrated
that SKPs, only when deleted for the Nf1 gene, form neurofibromas when autologously
transplanted into the sciatic nerve of mice, suggesting that neurofibroma tumours are
caused by dysregulated NCPCs (Le et al., 2009).
Neural crest-derived cells have also been implicated in tissue fibrosis. In a model of
renal fibrosis, it was shown that resident connective tissue cells of neural crest origin
transdifferentiated into myofibroblasts, were highly proliferative, and predominantly
contributed to the fibrotic phenotype induced by unilateral ureteral obstruction (Asada et
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al., 2011). In the skin, it was shown that Sox2-expressing progenitor-like cells contribute
to the myofibroblast population during bleomycin-induced skin fibrosis, a model of
scleroderma (Liu et al., 2013). Since SKPs are transcriptionally and functionally similar
to DP cells, investigating the molecular mechanisms of SKP differentiation thus
represents a novel in vitro model to study this fibrogenic phenomenon.

1.2

Overview of Tissue Fibrosis

Tissue fibrosis is implicated in approximately 45% of all deaths in the western world,
and is a common final pathway in diabetes, cardiovascular disease, interstitial lung
diseases, chronic kidney disease, liver cirrhosis, scleroderma and more. (Wynn, 2007)
Fibrotic diseases are characterized by excessive scarring, which results from excessive
production, deposition, and contraction of the extracellular matrix (Leask, 2004). No
effective treatments currently exist for any fibrotic condition. Consequently, fibrotic
diseases currently represent one of the largest groups of diseases for which there is no
therapy (Leask, 2004). Fibrosis can occur in nearly all organs including the skin, heart,
lung, liver and kidney, typically as a result of damage or inflammation (Hinz, 2007).

1.2.1 The Myofibroblast
Fibrosis is mediated by the excessive accumulation of specialized mesenchymal cells
called myofibroblasts at the site of injury (Leask and Abraham, 2004). Myofibroblasts are
a differentiated, contractile, and invasive form of fibroblasts characterized by the
formation of stress fibers expressing the contractile protein α-smooth muscle actin (αSMA) (Hinz et al., 2003). Expression of α-SMA increases intracellular mechanical stress
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and is associated with a greatly enhanced adhesive capability via the “supermaturation”
of cellular focal adhesions with the extracellular matrix (Hinz et al., 2003).
Myofibroblasts are essential for tissue repair during wound healing, but are abnormally
present and pathologically persistent in fibrotic diseases, resulting in excessive matrix
deposition, scarring and the destruction of normal tissue architecture (Hinz et al., 2007).
Elucidating the origins of myofibroblasts in fibrotic diseases and understanding the
mechanisms behind their formation is paramount to developing effective treatments
(Quaggin and Kapus, 2011).

1.2.2 Origin of Myofibroblasts in Fibrosis
During the normal wound healing response, local fibroblasts undergo transforming
growth factor-beta (TGF-β) induced differentiation into myofibroblasts in order to
contract the wound edges and gradually reduce its size (Leask and Abraham, 2004).
After tissue repair is complete, these myofibroblasts undergo apoptosis. Due to the
presence of myofibroblasts in both tissue repair and fibrotic diseases, it has traditionally
been hypothesized that fibrosis occurs due to the failure to terminate the tissue repair
response (Gabbiani, 2003). However, evidence suggests that myofibroblasts in
pathological tissue fibrosis are not derived solely from resident fibroblasts, and it is now
appreciated that these myofibroblasts may originate from multiple sources including the
differentiation of resident mesenchymal progenitor cells, epithelial-to-mesenchymal
transition, and the recruitment of bone marrow-derived fibrocytes (Hinz, 2007; Figure
1.1). Recently, studies using genetic fate-mapping approaches have identified various
populations of progenitor cells including pericytes, fibrocytes, and neural crest-like
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precursors as being major sources of myofibroblasts in models of kidney, liver, lung and
skin fibrosis (Hung et al., 2013; Iwaisako et al., 2012; Lin et al., 2008, Asada et a., 2011).

Figure 1.1 Differentiated myofibroblasts originate from various origins.
Myofibroblasts in fibrotic diseases have been speculated to originate from several sources
including the differentiation of locally residing mesenchymal cells such as fibroblasts,
hepatic stellate cells (HSC) and smooth muscle cells (SMC) as well as from epithelial to
mesenchymal transition (EMT), and the accumulation and differentiation of bone-marrow
derived fibrocytes. (Adapted with permission from Figure 2. The myofibroblast: One
function, multiple origins. Hinz B, Phan SH, Thannickal VJ, Galli A, Bochaton-Piallat
ML, Gabbiani G. Am J Pathol. 2007;170(6):1807-1816. doi:
10.2353/ajpath.2007.070112.)
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1.2.3 Inducers of Myofibroblast Differentiation
The most well characterized inducer of myofibroblastic differentiation is TGF-β, a
multifunctional protein involved in a broad spectrum of biological responses. In its
canonical signaling pathway, TGF-β binds to its cognate receptors and phosphorylates
Smad proteins, driving changes in gene expression and the induction of a contractile
phenotype in a variety of cell types (Leask and Abraham, 2004). However, targeting
TGFβ directly has been shown to be an ineffective treatment for fibrotic diseases. In a
clinical trial with scleroderma patients, treatment with a TGF-β neutralizing antibody
resulted in serious adverse effects, likely due its important anti-inflammatory role
(Denton et al., 2007; Yanagita, 2012). As such, downstream mediators of the pro-fibrotic
transcriptional program have been investigated as potential therapeutic targets. Previous
studies have shown that the differentiation of dermal and lung fibroblasts is dependent on
adhesion-mediated signaling through the activation of the non-receptor tyrosine kinase
focal adhesion kinase (FAK) (Shi-wen et al., 2012; Lagares et al., 2012). When activated
by phosphorylation, FAK forms a complex with c-Src (Src), a member of Src-family
tyrosine kinases, and induces a signaling cascade involved in cytoskeleton reorganization,
matrix contraction, and profibrotic gene expression (Liu et al., 2007). Recent studies have
also identified myocardin-related transcription factor-A (MRTF-A), also known as
MLK1, as a transcriptional coactivator induced by Rho GTPases that physically
associates with serum response factor (SRF) to induce gene expression associated with
myogenic differentiation and cytoskeletal reorganization (Scharenberg et al., 2014).
Knockdown of MRTF-A has been shown to impair fibroblast-to-myofibroblast
differentiation in vitro, and chemical inhibition of the MRTF-A/SRF pathway has also
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recently been shown to prevent bleomycin-induced skin fibrosis (Crider et al., 2011;
Haak et al., 2014). How the FAK/Src and SRF pathways are interrelated has not been
fully elucidated. However, one proposed model suggests that the formation of focal
adhesions between integrins and the extracellular matrix, and the subsequent activation of
the FAK/Src complex is an initiating factor that drives actin polymerization through
RhoA (Olsen and Nordheim, 2010). Under this model, the polymerization of globular
actin into filamentous actin liberates globular actin-coupled MRTF-A, which induces the
nuclear transcription factor SRF and in turn activates a cascade of pro-fibrotic and
contractile signaling (Figure 1.2).

13

Figure 1.2 Serum response factor (SRF) is activated by actin microfilament
dynamics resulting from altered adhesive signaling. Formation of focal adhesions
between integrins and the extracellular matrix activates the FAK/Src complex. FAK/Src
is capable of activating Rho signaling, which results in the incorporation of globular (G)actin into filamentous (F)-actin and the liberation of myocardin-related transcription
factor (MRTF). MRTF enters the nucleus to activate SRF and initiates a cascade of profibrotic gene expression. (Adapted with permission from Figure 1. Linking actin
dynamics and gene transcription to drive cellular motile functions. Olson EN, Nordheim
ANat Rev Mol Cell Biol. 2010;11(5):353-365. doi: 10.1038/nrm2890;
10.1038/nrm2890.)
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1.2.4 CCN2 (CTGF)
The CCN (CYR61, CTGF, NOV) family consists of six matricellular proteins
characterized by four conserved cysteine-rich domains: the insulin-like growth factorbinding domain, the Von Willebrand factor type C domain, the thrombospondin type 1
and a C-terminal domain with a cysteine knot motif. As matricellular proteins, members
of the CCN family are dynamically expressed, non-structural proteins secreted into the
extracellular matrix (ECM) that have regulatory roles. CCN2, also known as connective
tissue growth factor (CTGF), is a marker and mediator of fibrosis that represents an
intriguing anti-fibrotic target (Leask et al., 2009). Other members of the CCN family
include CCN1 (Cyr61), which has an in vitro effect similar to CCN2, CCN3 (Nov) which
is a natural inhibitor of both CCN1 and CCN2, and CCN4-6 (WISP1, WISP2, WISP3)
which are Wnt-induced signaling proteins associated with diverse cellular functions (Liu
et al., 2014; Leask, 2009). CCN2 is highly induced during both wound healing and
fibrosis. Interestingly however, conditional deletion of CCN2 in skin prevents bleomycininduced myofibroblast formation, skin thickening, and collagen production but does not
affect wound repair kinetics, suggesting that CCN2 has fibrosis-specific effects (Liu,
2011). CCN2 is activated during myofibroblast differentiation and is part of the
profibrotic gene program induced by various mechanisms including TGFβ, FAK, SRF
and mechanical stress (Leask, 2004; Graness et al., 2006; Muehlich et al., 2007). To
exert its effects, CCN2 is secreted by cells into the ECM, and acts in an autocrine and
paracrine fashion through integrins, growth factor receptors, and heparin sulfatecontaining proteoglycans to modulate cellular responses to growth factors and ECM
proteins (Chen et al., 2004; Figure 1.3). Known effects of CCN2 vary depending on cell
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type and microenvironment, but include cell adhesion, migration, transdifferentiation,
collagen deposition, proliferation and angiogenesis (Leask and Abraham, 2006).
Characteristically expressed by myofibroblasts, CCN2 is not expressed basally in the skin
except within the hair follicle DP, concomitantly with Sox2 (Liu et al., 2013). Our lab has
shown that genetic ablation of CCN2 within these Sox2-expressing cells reduces
bleomycin-induced skin fibrosis by preventing their recruitment and differentiation into
myofibroblasts within the fibrotic lesion (Liu et al., 2013). It is thus of interest to
investigate the role of CCN2 in the myofibroblastic differentiation of SKPs in order to
elucidate the mechanisms behind how precursor cells may contribute to fibrosis.

Figure 1.3 The matricellular protein CCN2 contains four cysteine-rich domains and
regulates pro-fibrotic signaling. Like other CCN family members, CCN2 contains a
insulin-like growth factor-binding domain, a Von Willebrand factor type C domain, a
thrombospondin type 1 and a C-terminal domain with a cysteine knot motif. CCN2 is
associated pro-fibrotic responses such as myofibroblast activation and excessive
extracellular matrix deposition as well as enhanced cell adhesion and migration.
(Adapted with permission from Figure 2. Could aging human skin use a connective tissue
growth factor boost to increase collagen content? Oliver N, Sternlicht M, Gerritsen K,
Goldschmeding R. J Invest Dermatol. 2010;130(2):338-341. doi: 10.1038/jid.2009.331;
10.1038/jid.2009.331.)
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1.3

Rationale, Objectives and Hypotheses

Sox2-expressing hair follicle stem cells have been shown to be capable of
differentiation into α-SMA-expressing myofibroblasts during skin fibrosis, while SKPs
cultured from dermal tissue express Sox2 and are transcriptionally similar to hair follicle
dermal papilla cells. Thus, SKPs represent a unique model to study this fibrogenic
phenomenon. However, the adult cells in the dermis from which SKPs are derived from
are unclear. Overall, the aims of this project were to (1) clarify the cellular origin of SKPs
from murine trunk skin and (2) elucidate the mechanism behind the differentiation of
SKPs into myofibroblast-like cells. Given that SKPs have been shown to originate from a
mesenchymal lineage, and that embryonic fibroblast cell lines are capable of generating
neurospheres, I hypothesized that adult dermal fibroblasts retained this plasticity and are
a major origin of SKPs. Furthermore, since CCN2 has been shown to be required for
Sox2-expressing cells to contribute to fibrosis in vivo, I hypothesized that CCN2 was also
a mediator of the ability of SKPs to differentiate into myofibroblasts.
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Materials and Methods
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2.1

Generation of Transgenic Mice

2.1.1 LacZ Reporter Mice
Mice hemizygous for a tamoxifen-dependant Cre recombinase under the control
of a fibroblast-specific Col1a2 promoter were bred with mice harbouring an inducible
LacZ transgene integrated into the ubiquitous Gt(ROSA)26Sor locus to generate Col1a2Cre(ER)T;Rosa26LacZ mice, as previously described (Liu and Leask, 2013). Expression
of the LacZ gene is prevented by a loxP-flanked (“floxed”) DNA STOP sequence until
the STOP sequence is excised by Cre recombinase. Thus, upon activation of Cre by
tamoxifen, cells expressing Col1a2 are permanently labeled by expression of LacZ.

2.1.2 Double Fluorescent Reporter Mice
Mice hemizygous for a tamoxifen-dependent Cre recombinase under the control
of either a Col1a2 or Sox2 promoter were bred with mice harbouring a doublefluorescent reporter transgene (mTmG) integrated into the ubiquitous Gt(ROSA)26Sor
locus to generate Col1a2-Cre(ER)T;Rosa26mTmG or Sox2-Cre(ER)T;Rosa26mTmG
mice, as previously described (Liu et al. 2013). The mTmG transgene results in
expression of membrane-targeted tdTomato prior to Cre-mediated excision and
membrane-targeted GFP after excision. Thus, upon activation of Cre by tamoxifen, cells
expressing Col1a2 or Sox2 in the respective mouse lines are permanently labeled by
expression of green fluorescent protein (GFP), while all other cells are labeled by
expression of tandem dimer (td) Tomato (Muzumdar, 2007).
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2.1.3 Conditional CCN2 KO Mice
Mice hemizygous for a tamoxifen-dependent Cre recombinase under the control
of a Col1a2 promoter (Col1a2-CreER(T)) were bred with mice harbouring
a floxed CCN2 allele to generate mice hemizygous for Col1a2-CreER(T) and
heterozygous for the floxed CCN2 allele. These mice were interbred to generate mice
hemizygous for Col1a2-Cre(ER)T and homozygous for the floxed CCN2 allele (Col1a2Cre(ER)T;CCN2fl/fl), as previously described (Liu et al., 2011). In the floxed CCN2 mice,
exon 4 of CCN2 is flanked by loxP sites and is excised upon Cre-mediated recombination
to eliminate gene function (Liu et al., 2011).

2.1.4 Induction of Cre Recombinase
A stock solution of tamoxifen (4-hydroxytamoxifen, Sigma, St. Louis, MO) in
ethanol (100 mg/ml) was diluted to a concentration of 10 mg/ml in corn oil (Sigma).
Three week old littermate mice were given 0.1 ml intraperitoneal injections of the
tamoxifen solution to induce Cre recombinase, or corn oil alone as a vehicle control for
five consecutive days. Col1a2-CreER(T);CCN2fl/fl mice injected with tamoxifen will
henceforth be referred to as Col1a2-CreER(T);CCN2-/-, while littermate mice injected
with corn oil with be referred to as Col1a2-CreER(T);CCN2fl/fl.

2.1.5 Genotyping
Polymerase chain reaction and subsequent agarose gel electrophoresis with
ethidium bromide staining was used to genotype the DNA of all experimental animals for
appropriate expression of Cre (Forward primer sequence 5′–
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ATCCGAAAAGAAAACGTTGA-3′; Reverse primer sequence 5′–
ATCCAGGTTACGGATATAGT-3′), LacZ (Fw 5’ – CGTGGCCTGATTCATTCC – 3’;
Rv 5’ –ATCCTCTGCATGGTCAGGTC –3’), mTmG (Fw 5’CTCTGCTGCCTCCTGGCTTCT-3’; Rv 5`-TCAATGGGCGGGGGTCGTT-3` and 5`TCAATGGGCGGGGGTCGTT-3` and 5`-CGAGGCGGATCACAAGCAATA-3`) and
floxed CCN2 (5’ – AATACCAATGCACTTGCCTGGATGG – 3’ 5’ –
GAAACAGCAATTACTACAACGGGAGTGG – 3’; Figure 2.1) as previously described
(Liu et al., 2013; Liu and Leask, 2013). All animal protocols were approved by the
animal care committee at Western University.

A
B

Figure 2.1 Agarose gel electrophoresis of DNA from CCN2+/+ and CCN2fl/fl mice.
DNA was extracted from mouse ear notch samples and amplified by polymerase chain
reaction using the forward and reverse primers 5’ –
AATACCAATGCACTTGCCTGGATGG – 3’ and 5’ –
GAAACAGCAATTACTACAACGGGAGTGG – 3’. Amplified DNA was subjected to
agarose gel electrophoresis and visualized with ethidium bromide to detect (A) wild type
(1003 bp) and (B) homozygous floxed (878 bp) CCN2 alleles.
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2.2

Cell Culture

2.2.1 Isolation of SKPs (Direct Method)
SKPs were isolated from the dermis of mice as previously described (Fernandes et
al, 2004). Briefly, two large flaps of dorsal skin were excised from each mouse and
incubated with a 2 mg/ml collagenase solution (Worthington Biochemical, New Jersey,
USA, cat # LS004176) for 3 hours in a 37 °C, 5% CO2 tissue-culture incubator. Dermal
tissue was then separated from the epidermis and mechanically digested with a transfer
pipette. Debris was removed after low-speed centrifugation, and cells were subsequently
pelleted by centrifugation at 250 g for 5 minutes. Cell pellets were re-suspended in SKP
growth medium, filtered with a 40 µm cell strainer (VWR, cat # 21008-949) and
transferred to 75cm2 flasks (VWR, Mississauga, ON, Canada, cat # 82050-856). SKP
growth medium contained DMEM-F12 (3:1) (cat #s 10566-016 and 11765-062)
supplemented with 2% B-27 (cat # 17504044), 1% N-2 (cat # 17502-048), 40 ng/ml EGF
(cat # PHG0311), 40 ng/ml bFGF (cat # PHG0021) (all from Life Technologies) and 1%
chick embryo extract (Cedar Lane, Hornby, ON, Canada, cat # C3999). Every 2-3 days,
40 ng/ml EGF and 40 ng/ml bFGF were added the culture medium. SKPs were passaged
after 2 weeks of growth by mechanical dissociation with a P1000 pipette and reseeding
into 100 mm x 15 mm petri dishes (VWR, cat # 25384-088) at a concentration of 50 000
cells/ml.
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2.2.2 Directed Differentiation of SKPs into Myofibroblast-like Cells
After passaged SKPs had grown for 2 weeks, spheroids were transferred to 15 ml
conical tubes (VWR, cat # 21008-931), centrifuged at 250 g for 5 minutes and gently
resuspended in DMEM:F12 (3:1). Spheroids were then plated on 6 well culture plates
(VWR, cat # 82050-842) that had been coated overnight with poly-L-lysine (Sigma, cat #
P4707) and laminin (Life Technologies, cat # 23017-015). At this point, when applicable,
cells were treated with the Src-family kinase inhibitor PP2 (10 µM, EMD Millipore),
FAK inhibitor PF228 (10 µM, Sigma), or MRTF-A/SRF inhibitor CCG-1423 (50 µM,
Sigma) and incubated for 30 minutes at 37°C. To induce differentiation, cells were
treated with 0.5% FBS (Life Technologies, cat # 16000-044) and incubated for 24 hours
at 37°C before analysis.

2.2.3 Culture of MDFs
Mouse dermal fibroblasts (MDFs) were cultured from the dorsal skin of mice as
previously described (Liu et al., 2011). Briefly, two large flaps of dorsal skin were
excised from each mouse and incubated with a 2 mg/ml collagenase solution for 3 hours
in a 37 °C, 5% CO2 tissue-culture incubator. Dermal tissue was then separated from the
epidermis and mechanically digested with a transfer pipette. Debris was removed after
low-speed centrifugation, and cells were subsequently pelleted by centrifugation at 250 g
for 5 minutes. Cell pellets were re-suspended in fibroblast growth medium consisting of
Dulbecco’s Modified Eagle’s Medium (DMEM, Life Technologies, Burlington, ON,
Canada, cat # 11965-092) supplemented with 10% FBS and transferred to 75cm2 flasks.
Growth medium was replaced every 2-3 days. Upon reaching approximately 90%
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confluence, adherent cells were detached by incubation with 0.25% trypsin/EDTA (Life
Technologies, cat # 25200-072) in DMEM at 37 °C for 5 minutes and split into 100 mm
x 20 mm culture dishes (VWR, cat # 82050-916) containing fresh growth medium.

2.2.4 Generation of MDF-SKPs
To generate SKPs from monolayer MDFs (MDF-SKPs), MDFs were first grown
to approximately 90% confluence in 100 mm x 20 mm culture dishes and incubated with
0.25% trypsin/EDTA in DMEM as outlined above. Cells were then transferred to 15 ml
conical tubes containing SKP base medium and centrifuged at 250 g for 5 minutes to
produce cell pellets. The pellets were then re-suspended in SKP growth medium at a
concentration of 50 000 cells/ml and seeded in 6 well culture plates at 3 ml per well. 40
ng/ml of EGF and 40 ng/ml bFGF were added the culture medium every 2-3 days.

2.2.5 Multi-lineage Differentiation of MDF-SKPs
Differentiation was induced as previously described for SKPs (Fernandes and
Miller, 2009). 6 well culture plates (VWR, cat # 82050-842) were coated overnight with
poly-L-lysine (Sigma, cat # P4707) and laminin (Life Technologies, cat # 23017-015)
and subsequently washed twice with sterile water. MDF-SKP spheroids were transferred
from the uncoated 6 well plates from which they were grown into 15 ml conical tubes and
centrifuged at 250 g for 5 minutes to generate a cell pellet. The cell pellets were gently
re-suspended in differentiation medium and seeded onto the poly-L-lysine and laminin
coated 6 well plates. For neural-directed differentiation, cells were plated in SKP base
medium supplemented with 5% FBS and 40 ng/ml bFGF for 5 days. Cells were then
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cultured for 5 additional days in fresh SKP base medium supplemented with 5% FBS and
40 ng/ml nerve growth factor (NGF; Life Technologies, cat #13257-019). For generalized
differentiation and detection of myofibroblasts, spheroids were plated in SKP base
medium supplemented with 5% FBS for 5 days.

2.2.6 Additional Information
All cell culture media used were also supplemented with 1% antibioticantimycotic solution (Life Technologies, cat # 15240-062).

2.3

Immunocytochemistry and cell microscopy

Immunocytochemical analysis of both spheroids and adherent cells were
performed directly on 6 well cell culture plates. Briefly, cells were fixed with 4%
paraformaldehyde (Sigma) for 10 minutes, washed with phosphate buffered saline (PBS;
Sigma), and permeabilized with PBS + 0.5% Triton X-100 (PBS-T; Sigma) for 10
minutes. Cells were then incubated with blocking solution consisting of PBS-T + 10%
donkey serum (Jackson Immunoresearch, West Grove, PA, USA) for 30 minutes at room
temperature and incubated overnight at 4°C with primary antibody diluted in blocking
solution. Cells were then washed with PBS and incubated with secondary antibody
diluted in blocking solution for 1 hour. Finally, cells were incubated with Hoescht dye
(Sigma) and washed again with PBS. The following primary antibodies were used: antiα-SMA monoclonal (1:500, Sigma), anti-βIII-Tubulin monoclonal (1:1000,
PhosphoSolutions, Aurora, CO, USA), anti-GFP monoclonal (1:100, Santa Cruz
Biotechnology, Dallas, TX, USA), anti-Nestin monoclonal (1:100, Santa Cruz
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Biotechnology), anti-Sox2 polyclonal (1:100, Santa Cruz Biotechnology), anti-CCN2
polyclonal (1:100, Santa Cruz) and anti-Ki67 polyclonal (1:1000, Abcam). The following
secondary antibodies were used: Alexa Flour 488-conjugated donkey anti-rabbit
(1:1000), Alexa Flour 488-conjugated donkey anti-goat (1:1000), Alexa Flour 594conjugated donkey anti-mouse (1:1000) and Alexa Flour 594-conjugated donkey antirabbit (1:1000); all were purchased from Jackson Immunoresearch. A Leica
Microsystems DM16000B fluorescent microscope and DFC360FX camera were used for
all cell imaging, including the detection of GFP and tdTomato expression in live cells
from mTmG reporter mice.

2.4

Histology

Dorsal skin samples were fixed for 24 hours in 4% paraformaldehyde. Tissue
samples were subsequently cryoprotected in 30% sucrose (Sigma) overnight, embedded
in Tissue-Tek Optimal Cutting Temperature compound (VWR, cat # 25608-930) and
frozen at -80°C for one hour. Sections (10 µm) were cut immediately afterwards using a
Leica CM1900 UV cryostat (Leica, Concord, ON, Canada) and collected on Superfrost
Plus slides (Fisher Scientific, Ottawa, ON, Canada). To detect GFP and tdTomato
expression in mTmG reporter mice, slides were then washed in PBS, mounted using 4′,6diamidino-2-phenylindol (DAPI, Vector Labs, Burlington, ON, Canada), and
photographed using a Zeiss Imager M1 ﬂuorescence microscope (Toronto, ON, Canada)
and Northern Eclipse software (Empix, Mississauga, ON, Canada).

26

2.5

X-Gal Staining

For X-Gal staining to detect LacZ expression in skin tissue cryosections or
cultured SKP spheroids, samples were fixed for 5 minutes with fixative solution
consisting of 4% paraformaldehyde and 0.5% glutaraldehyde (Sigma). Samples were then
washed with PBS, and incubated overnight at 37°C with X-Gal staining solution (Life
Technologies, cat # K1465-01). Samples were subsequently washed again with PBS
before analysis. X-Gal stained SKP spheroids were imaged using a Leica EC3 camera
and a Leica S6-D microscope; cryosections were imaged using a Leica DFC295 camera
and DM1000 microscope.

2.6

Cell Viability Assay

The viability of MDF-SKPs at 3, 9 and 15 days after trypsinization of MDFs was
assayed in the following media conditions: DMEM-F12(3:1) supplemented with 2% B27,
1% N2, 1% chick embryo extract, 40 ng/ml EGF and 40 ng/ml bFGF (Full), DMEM-F12
(3:1) supplemented with 2% B27 and 40 ng/ml bFGF (B27+FGF), DMEM-F12 (3:1)
supplemented with 40 ng/ml bFGF (FGF), DMEM-F12 (3:1) supplemented with 40
ng/ml EGF (EGF) or DMEM-F12 (3:1) alone (Base). PrestoBlue reagent (Life
Technologies, cat # A-13261) was used according to the manufacturer’s instructions to
quantify cell viability. Cells from three mice were assayed in triplicate for each timepoint
and treatment. One-way ANOVA was used to determine significant differences (p<0.05)
at each time point.

27

2.7

Real Time RT-PCR

RNA was extracted using the TRIzol (Life Technologies) and chloroform (Sigma)
method as previously described. RNA samples were analyzed with a Nanodrop
Spectrophotometer (Thermo Scientific, Waltham, MA, USA) to determine RNA
concentration and integrity. Only samples with a measured 280/260 ratio above 1.8 were
used for real time RT-PCR analysis and 40 ng RNA samples were run in triplicate. RNA
was reverse transcribed and amplified in a 15 μl reaction using TaqMan Assays on
Demand primers, 6-carboxyfluroscein-labeled TaqMan MGB probe and Reverse
Transcriptase qPCR One-step Mastermix (Quanta, VWR, Mississauga, ON, Canada).
ABI Prism 7900 HT sequence detector (Perkin-Elmer-Cetus, Vaudreuil, QC, Canada)
was used according to the manufacturer's instructions to detect amplified sequences.
Expression values were standardized to control values from 18S primers using the ΔΔCt
method. Statistical analysis on three independent experiments was done using Student's ttest on GraphPad Prism.

2.8

Western Blot

To harvest protein, cells were first washed with PBS for 5 minutes and then lysed
with Radioimmuno-precipitation Assay (RIPA) lysis buffer (150 mM NaCl, 50 mM Tris–
HCl pH 7.5, 1 % Triton-X, 1 % deoxycholate, 0.1 % SDS, 2 mM EDTA; all from Sigma)
supplemented with a protease inhibitor (Roche). Cell lysates were sonicated three times
for 10 seconds at 10 minute intervals before being centrifuged for 12 minutes at 12 000
RPM to remove debris. Lysates were quantified by a bicinchronic protein assay (BCA,
Thermo Scientific) according to the manufacturer’s instructions. Equal quantities of
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protein (25 μg) were brought to an equal volume with RIPA buffer, mixed with 6x
loading dye (Thermo Scientific) and boiled at 99°C for 5 minutes. Protein mixtures were
subsequently loaded onto 10x sodium dodecyl sulfate (SDS) gels and run at 120V for ~2
hours using the XCell SureLock™ Mini-Cell electrophoresis system (Invitrogen) in the
presence of 1X Running buffer (5 mM Tris; 40 mM Glycine; 0.02% SDS) according to
the manufacturer’s instructions. Resultant gels were transferred to a nitrocellulose
membrane using the iBlot dry-transfer system (Invitrogen, Burlington, ON, Canada)
according to the manufacturer’s instructions. Membranes were then blocked for 1 hour in
5 % non-fat dry milk in Tris-buffered saline with 0.01 % Tween-20 (TBST, Sigma), and
incubated with anti-α-SMA (1:2500; Sigma), anti-CCN2 (1:100; Santa Cruz), anti-PCNA
(1:500 Abcam), or anti-β-actin (1:5000, Sigma) antibodies diluted in the same solution
overnight at 4 °C. Blots were washed 3 times for 5 min with TBST, incubated with the
appropriate horse radish peroxidase (HRP)-conjugated secondary antibodies (Jackson
Immunoresearch, West Grove, PA, USA) for 1 hour at room temperature and then
developed with SuperSignal™ West Pico Chemiluminescent Substrate (Thermo
Scientific) according to the manufacturer’s instructions. Membranes were finally
visualized using X-ray film (Sigma), and scanned to a digital format (Hewlett-Packard).
Relative densities of bands were quantified using ImageJ 1.46 software (National
Institutes of Health, Bethesda, MD, USA).

2.9

Genome-wide expression profiling

Expression profiling was conducted at the London Regional Genomics Centre (David
Carter, Robarts Research Institute, London, Canada), essentially as previously described
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(Guo et al., 2014), for two independent sets of Col1a2-CreER(T);CCN2fl/fl and Col1a2CreER(T);CCN2-/- SKPs treated with 0.5% FBS for 24 hours. RNA samples were
collected using the TRIZol and chloroform method and quality was assessed using a
bioanalyzer (Agilent Technologies, Palo Alto, CA). 200 ng of total RNA was used to
prepare single-stranded complimentary DNA using the Ambion® WT Expression Kit as
per the manufacturer’s instructions (Affymetrix, Santa Clara, CA, USA). Target
preparation was subsequently performed using the GeneChip® WT Terminal Labeling
and Controls Kit. Resultant single stranded, end labeled cDNA was hybridized for 16 h at
45°C to a GeneChip® Mouse Gene 2.0 ST Array. All liquid-handling steps were
performed by a GeneChip Fluidics Station 450, and GeneChips were scanned with the
GeneChip Scanner 3000 7G (Affymetrix) using Command Console, version 1.1. Probelevel (.CEL file) data were generated using Affymetrix Command Console, version 1.1.
Probes were summarized to gene-level data in Partek Genomics Suite, version 6.5
(Partek, St. Louis, MO) using the RMA algorithm. Partek was used to determine genelevel analysis of variance (ANOVA) p values and fold changes. Genes with a fold change
greater than |1.4| with a p value less than 0.01 were filtered and analyzed using functional
annotation clustering (DAVID Functional Annotation Software)
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3

Results

31

3.1
SKP spheroids express neural stem cell markers
Sox2 and Nestin
To confirm that the SKPs isolated in our culture conditions were similar to those
described elsewhere in the literature, SKP spheroids I isolated directly from the dermis of
mouse dorsal skin were, after two weeks of culture, subjected to indirect
immunofluorescence analysis using anti- α-SMA, anti-Sox2 and anti-Nestin antibodies. I
define SKPs cultured by this method as ‘directly-cultured SKPs’. All spheroids
consistently showed cells with nuclear Sox2 expression, cytoplasmic Nestin expression,
and α-SMA expression along the outer edges of the sphere (Figure 3.1), as has been
reported by others (Biernaskie et al., 2009). Sox2 and Nestin are markers expressed by
multipotent neural stem cells cultured in vitro and are also expressed by hair follicle stem
cells in the skin (Driskell et al., 2011).
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100 µm

Figure 3.1 SKP spheroids express α-SMA, Sox2 and Nestin. SKP spheroids were fixed
in 4% paraformaldehyde and subjected to immunofluorescence staining with primary
antibodies against α-SMA and the previously described SKP markers, Sox2 and Nestin.
Nuclei were stained with Hoechst dye (blue). Representative images are shown.

33

3.2

Few SKPs are derived from Sox2-expressing cells

Although SKP spheroids expressed Sox2, it was unclear whether they originated
from cells expressing Sox2 in vivo or whether Sox2 expression was being induced in
vitro. To test this, I performed lineage tracing using mice induced to permanently express
GFP in Sox2-expressing cells (or tdTomato in all other cells). Three week old Sox2CreER(T);Rosa26mTmG mice were injected with tamoxifen at 3 weeks of age for 5
consecutive days. Mice were subsequently sacrificed and dorsal skin was either used to
culture SKPs or was flash frozen and cryosectioned. Fluorescence microscopy was used
to detect GFP and tdTomato expression in cryosections and cultured SKPs. Although
histological analysis of skin tissue sections revealed Sox2-GFP expression in the dermal
papilla (DP) and dermal sheath (DS) of the hair follicle, consistent with previous studies
(Driskell et al., 2011), SKPs cultured from these mice contained very few GFP+ cells.
(Figure 3.2)
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Figure 3.2 Few SKP spheroids are derived from Sox2-expressing cells. Sox2CreER(T);Rosa26mTmG reporter mice were injected with tamoxifen at 3 weeks of age
for 5 consecutive days and subsequently sacrificed. Dorsal skin was either used to culture
SKPs or was flash frozen and cryosectioned. Fluorescence microscopy was used to detect
GFP and tdTomato expression in cryosections and cultured SKPs. Representative images
are shown.
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3.3
SKP spheroids are largely derived from Col1a2expressing dermal fibroblasts
To determine if SKPs originated from type I collagen-expressing dermal
fibroblasts, I performed lineage tracing by using mice induced to permanently express
LacZ in Col1a2-expressing cells. Three week old Col1a2-CreER(T);Rosa26LacZ mice
were injected with either tamoxifen to induce reporter expression or corn oil (Control) at
3 weeks of age for 5 consecutive days. Mice were subsequently sacrificed and dorsal skin
was either used to culture SKPs or was flash frozen and cryosectioned. X-Gal staining
solution was used to detect β-galactosidase expression in both cryosections and cultured
SKPs. Histological analysis revealed widespread β-galactosidase expression in dermal
fibroblasts within the connective tissue, consistent with previous studies using this
reporter (Ponticos et al., 2003); SKPs cultured from these mice also stained strongly with
X-Gal (Figure 3.3).
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Figure 3.3 SKP spheroids are largely derived from Col1a2-expressing dermal
fibroblasts. Col1a2-Cre(ER)T;Rosa26LacZ mice were injected with either tamoxifen or
corn oil (Control) at 3 weeks of age for 5 consecutive days. Mice were subsequently
sacrificed and dorsal skin was either used to culture SKPs or was flash frozen and
cryosectioned. X-Gal staining solution was used to detect β-galactosidase expression in
both cryosections (upper) and cultured SKPs (lower). Representative images are shown.
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3.4
Col1a2-expressing dermal fibroblasts grown in
monolayer are converted to Sox2+, Nestin+ SKP
spheroids after re-seeding in SKP medium
To test whether mouse dermal fibroblasts (MDFs) could be cultured in monolayer
and subsequently converted to SKPs, MDFs from C57/BL6 mice were cultured in
DMEM supplemented with 10% FBS. After cells were cultured to approximately 90%
confluence, the monolayer was trypsinized, pelleted, and re-seeded in the aforementioned
SKP proliferation medium consisting of a mixture of DMEM:F12 (3:1), 2% B-27, 1% N2, 1% Chick Embryo Extract, 40 ng/ml bFGF and 40 ng/ml EGF. Within 48 hours,
spheroids identical in appearance to directly-cultured SKPs began to form (Figure 3.4A).
To confirm that MDF-SKPs were ultimately derived from Col1a2-expressing cells in the
MDF monolayer, lineage tracing was performed using Col1a2-CreER(T);Rosa26mTmG
reporter mice that had been injected with tamoxifen at 3 weeks of age for 5 consecutive
days and subsequently sacrificed. It was found that the majority of cells in the MDF
monolayer expressed GFP, as did the majority of cells in the resultant MDF-SKPs
(Figure 3.4B). Following the protocol for direct SKP culture, 40 ng/ml bFGF and 40
ng/ml EGF were added to the culture medium every 2-3 days, and cells were grown for
two weeks before analysis. Indirect immunofluorescence analysis of spheroids revealed
nuclear localization of Sox2 and cytoplasmic localization of Nestin, consistent with the
expression pattern of directly-cultured SKPs (Figure 3.4C). Furthermore, real time RTPCR analysis revealed significantly upregulated mRNA expression of Sox2 and Nestin in
MDF-SKPs compared to MDFs from the same mice (Figure 3.4D).
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Figure 3.4 Col1a2-expressing dermal fibroblasts grown in monolayer are converted
to Sox2+, Nestin+ SKP spheroids via re-seeding in SKP medium. Primary mouse
dermal fibroblasts (MDFs) were cultured in DMEM supplemented with 10% FBS. When
grown to approximately 90% confluence, the monolayer was trypsinized and re-seeded in
serum-free SKP proliferation medium consisting of a 3:1 mixture of DMEM/F12 (3:1)
supplemented with B27/N2/Chick Embryo Extract/bFGF/EGF. (A) Representative phase
contrast images of monolayer MDFs and resultant MDF-SKPs grown for 48 hours. (B)
Lineage tracing of MDFs and MDF-SKPs cultured from Col1a2CreER(T);Rosa26mTmG mice reporter mice. (C) Indirect immunoflourescence
performed on MDF-SKPs against Sox2 and Nestin. (D) Real time RT-PCR analysis
comparing Sox2 and Nestin mRNA expression in monolayer MDFs and MDF-SKPs.
Error bars represent ± SEM (*= p<0.05; Student’s t-test; N=3)
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3.5
bFGF is sufficient to induce formation and growth
of Sox2+, Nestin+ MDF-SKPs
In order to determine the component(s) within SKP growth medium essential for
the formation and proliferation of SKPs, MDFs were trypsinized and reseeded in either
full SKP growth medium or DMEM-F12 (3:1) supplemented with either B27 + bFGF,
bFGF alone, EGF alone, or no supplementation, as described in full detail in the materials
and methods section (Figure 3.5A). Cell growth at 3, 9 and 15 days after re-seeding was
assessed with PrestoBlue cell viability reagent (Figure 3.5B). At the 3 day time point,
MDFs reseeded in full SKP proliferation medium, B27+bFGF, bFGF alone and EGF
alone all formed spheroids while those reseeded in B27 alone or base medium did not.
MDFs reseeded in full SKP proliferation medium and B27+FGF formed significantly
larger spheroids than those reseeded in FGF or EGF alone. At day 9, spheroids in the full,
B27+FGF and FGF groups experienced significant growth from day 3 (P<0.01; P<0.01;
P<0.05; Two-Way ANOVA), while the EGF group did not grow significantly (P>0.05;
Two-Way ANOVA). By day 15, the FGF group had grown as much as the full and
B27+FGF groups, while the viability of the EGF group had declined. Real time RT-PCR
analysis showed that MDF-SKPs grown with bFGF treatment alone were induced to
express significantly increased levels of Sox2 and Nestin mRNA over parental MDFs
(Figure 3.5C).
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Figure 3.5 bFGF is sufficient to induce formation and growth of Sox2+, Nestin+
MDF-SKPs. (A) Primary MDFs were trypsinized and re-seeded in serum-free
DMEM/F12 medium containing either B27+N2+Chick Embryo Extract+bFGF+EGF
(Full), B27+bFGF, bFGF, EGF, B27, or without any supplement (Base) and imaged at 3,
9 or 15 days. (B) Cell viability at 3, 9 and 15 days was assessed by PrestoBlue assay
(Different letters indicate significant differences within time points; One-Way ANOVA;
N=3), (C) Real time RT-PCR was used to compare Sox2 and Nestin mRNA expression in
monolayer MDFs and MDF-SKPs grown in bFGF alone for 15 days. Error bars represent
± SEM. (*= p<0.05;***=p<0.001; Student’s t-test; N=3).
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3.6
Neuronal and myofibroblast-like progeny of MDFSKPs can be traced to a fibroblastic origin
To trace whether Col1a2-expressing cells could differentiate into other cell types
after forming MDF-SKPs, MDFs were cultured from Col1a2-CreER(T);Rosa26mTmG
reporter mice that had been injected with tamoxifen at 3 weeks of age for 5 consecutive
days. MDFs were grown to 90% confluence and converted to MDF-SKPs via
trypsinization and reseeding in DMEM-F12 (3:1) supplemented with 40 ng/ml bFGF.
MDF-SKPs were grown for 2 weeks with the addition of 40 ng/ml bFGF every 2-3 days.
For neural differentiation, cells were plated in SKP base medium supplemented with 5%
FBS and 40 ng/ml bFGF for 5 days. Cells were then cultured for 5 additional days in
fresh SKP base medium supplemented with 5% FBS and 40 ng/ml nerve growth factor.
Indirect immunofluorescence analysis was subsequently performed using anti- GFP
antibody and an antibody detecting the neural-specific marker BIII-Tubulin (Fernandes
and Miller, 2009) (Figure 3.6A). For generalized differentiation and detection of
myofibroblasts, spheroids were plated in SKP base medium supplemented with 5% FBS
for 5 days. Immunocytochemistry was subsequently performed against the GFP and the
myofibroblast marker α-SMA (Figure 3.6B). Numerous βIII-Tubulin/GFP and αSMA/GFP double positive cells were detected, indicating that cells originally expressing
Col1a2 had differentiated into neural and myofibroblast-like cells.
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Figure 3.6 Neuronal and myofibroblast-like progeny of MDF-SKPs can be traced to
a fibroblastic origin. MDFs were cultured Col1a2-CreER(T);Rosa26mTmG reporter
mice. Upon reaching confluence, MDFs were subsequently trypsinized and re-seeded in
serum-free DMEM/F12 medium containing 40ng/mL bFGF. Resultant MDF-SKPs were
differentiated in the presence (A) or absence (B) of nerve growth factor.
Immunofluorescence staining was performed against βIII Tubulin/GFP and α-SMA/GFP
to detect neuronal and myofibroblast-like cells ultimately derived from Col1a2expressing fibroblasts. Representative images are shown.

43

3.7
SKPs are induced to express α-SMA, CCN2 and
CCN1 when treated with 0.5% FBS for 24 hours
To confirm that I could induce directed differentiation of SKPs into smooth
muscle or myofibroblast-like cells as described by others (Steinbach et al., 2011), SKPs
were cultured directly from the dermis of Col1a2-Cre;CCN2fl/fl (control) mice. Oncepassaged spheroids were plated onto poly-L-lysine and laminin coated 6 well plates in
medium containing DMEM/F12 (3:1) supplemented with or without 0.5% FBS. Resultant
cells were imaged by phase contrast microscopy (Figure 3.7A) before being harvested for
RNA. Real time RT-PCR analysis revealed that FBS-treated SKPs showed significantly
elevated expression of the myofibroblast marker α-SMA and the pro-fibrotic
genes/myofibroblast markers CCN2 and CCN1 (Figure 3.7B).
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Figure 3.7 SKPs are induced to express α-SMA, CCN2 and CCN1 when treated with
0.5% FBS for 24 hours. Directly cultured SKP spheroids were grown for two weeks and
plated onto poly-L-lysine and laminin coated 6 well plates in medium containing
DMEM/F12 (3:1) supplemented with or without 0.5% FBS for 24 hours. (A)
Representative phase contrast images of SKPs treated or not with FBS. (B) Real time RTPCR results for expression of the myofibroblast marker α-SMA and the pro-fibrotic
genes CCN2 and CCN1 in SKPs treated or not with FBS. Error bars represent ± SEM.
(*= p<0.05;**=p<0.01,***=p<0.001; Student’s t-test).
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3.8
Chemical inhibition of FAK/Src and MRTF-A/SRF
pathways prevents myofibroblastic SKP differentiation
and suppresses the activation of CCN1 and CCN2
After exposure to serum, SKPs were adherent to tissue culture plates and
exhibited radial spreading from the central spheroid. Since enhanced adhesive signaling
is known to be associated with myofibroblast formation, I tested whether inhibition of
pathways activated by adhesive signaling could prevent the differentiation of SKPs into
myofibroblasts. Upon the binding of integrins to the extracellular matrix during adhesion,
focal adhesion kinase (FAK) forms a complex with c-Src (a member of Src-family
kinases) to activate downstream signaling. Through Rho GTPases, FAK/Src signaling
can subsequently activate serum response factor (SRF), which induces the expression of
pro-fibrotic genes (Olson and Nordheim, 2012; Figure 1.2). To determine whether
FAK/Src and SRF signaling pathways were involved in myofibroblastic SKP
differentiation, SKP spheroids cultured from the dermis of Col1a2-Cre;CCN2fl/fl (control)
mice were pre-treated with DMSO or chemical inhibitors of Src-family kinases (PP2, 10
µM), FAK (PF228, 10 µM), or SRF (CCG-1423, 50 µM) for 30 minutes before 24h
incubation with 0.5% FBS to induce myofibroblastic differentiation (or DMSO and no
FBS as a control). FBS-treated SKPs pre-treated with PP2, PF228 and CCG-1423
exhibited significantly reduced α-SMA, CCN2 and CCN1 mRNA expression levels
compared to FBS-treated SKPs pretreated with DMSO and were similar to baseline levels
observed in SKPs untreated with FBS (Figure 3.8).
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Figure 3.8 Chemical inhibition of Src-family kinases, focal adhesion kinase, and
serum response factor prevents myofibroblastic differentiation of SKPs and
suppresses the activation of CCN1 and CCN2. SKP spheroids were pre-treated with
DMSO, PP2, PF228, or CCG-1432 for 30 minutes before 24h treatment with or without
(negative control) 0.5% FBS. RNA was harvested and subjected to real-time PCR
analysis for α-SMA, CCN2, and CCN1 expression. Three replicate trials were performed;
representative phase contrast microscopy images are shown (scale bar = 300 µm). Error
bars represent ± SEM. (*= p<0.05;**=p<0.01,***=p<0.001; One-way ANOVA).
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3.9
CCN2 knockdown in SKPs impairs myofibroblastic
differentiation without affecting proliferation
CCN2 is a marker and mediator of fibrosis, and is associated with the
differentiation of precursor cells into myofibroblasts (Leask et al., 2009; Liu et al., 2013;
Rosin et al., 2013; Li et al., 2010). Since CCN2 was highly expressed during seruminduced SKP differentiation, and was suppressed when differentiation was prevented by
FAK/Src and SRF inhibition, I tested whether CCN2 played a direct role in the
differentiation of SKPs into myofibroblasts. SKPs from Col1a2-CreER(T);CCN2fl/fl
(control) and Col1a2-CreER(T);CCN2-/- (conditional CCN2 KO) mice were treated with
0.5% FBS for 24h. Indirect immunofluorescence analysis showed that the majority of
cells differentiating from FBS-treated CCN2fl/fl SKPs spheroids co-expressed CCN2 and
α-SMA. In contrast, no CCN2 immunoreactivity was detected in cells from CCN2-/SKPs, coinciding with an apparent reduction of cells staining for α-SMA+ stress fibers
(Figure 3.3A). Real time PCR analysis showed a significant knockdown of CCN2 and
reduced α-SMA expression in CCN2-/- SKPs compared to CCN2fl/fl SKPs after treatment
with FBS (Figure 3.3B). To assess a potential role for CCN2 on cellular proliferation,
indirect immunofluorescence analysis was performed using an anti-Ki67 antibody, and
the percentage of positive nuclei in differentiated cells were compared between FBStreated CCN2fl/fl and CCN2-/- SKPs; no significant difference was observed (Figure
3.3C). Densitometry analysis on a western blot performed on cell lysates also showed a
reduction in α-SMA protein in FBS-treated CCN2-/- SKPs compared to CCN2fl/fl, and
showed no significant reduction in Proliferating Cell Nuclear Antigen (PCNA) (Figure
3.3D).
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Figure 3.9 Col1a2-specific CCN2 KO reduces myofibroblastic SKP differentiation.
SKPs cultured from Col1a2-CreER(T);CCN2fl/fl or Col1a2-CreER(T);CCN2-/- mice were
treated with 0.5% FBS for 24h. (A) Indirect immunofluorescence was performed with
anti-α-SMA, anti-CCN2 and anti-Ki67 antibodies. (B) Real time RT-PCR analysis was
performed to assess expression of α-SMA and CCN2 mRNA. Error bars represent ±
SEM. (*= p<0.05;**=p<0.01;***=p<0.001; One-way ANOVA; N=3). (C) Ki67-positive
nuclei were counted and expressed as a percentage of total differentiated cells (N=3;
average of 10 fields). (D) Western blot analysis was performed to assess expression of αSMA (42 kDa), CCN2 (38 kDa) and PCNA (29 kDa) protein using β-Actin (42 kDa) as a
loading control. Densitometry was performed using ImageJ software. Error bars represent
± SD. (*= p<0.05;**=p<0.01;***=p<0.001; One-way ANOVA; N=3).
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3.10 CCN2 knockdown results in changes in
extracellular matrix, cytoskeleton, cell adhesion and cell
motion-related gene expression.
Since knockout of CCN2 had a direct effect on the ability of SKPs to differentiate
into α-SMA-expressing cells, I sought to further elucidate the downstream effectors of
CCN2 by assessing genome-wide changes in gene expression. To do this, microarray
analysis was performed to compare the transcriptional profiles of Col1a2CreER(T);CCN2fl/fl and Col1a2-CreER(T);CCN2-/- SKPs in response to a 24 hour
treatment with 0.5% FBS. 143 differentially expressed genes were identified (fold change
> |1.4|, p<0.05, N=2; Supplemental Table 1). Cluster analysis was performed using
DAVID Functional Annotation Tool on these genes. Altered gene clusters included genes
related to the extracellular matrix, cytoskeleton, cell adhesion and cell motion (Table
3.1). Notably, four genes in the cytoskeleton cluster identified to be downregulated were
associated with contractile proteins (Acta1, Acta2, Myl9, Tagln). In the extracellular
matrix cluster, two ECM-degrading matrix metallopeptidases were upregulated (Mmp1a,
Mmp9), while a tissue inhibitor of metallopeptidases (Timp3), and a collagen gene
(Col12a2) were downregulated. In the cell adhesion and migration clusters, genes
previously as being essential for myofibroblast differentiation such as Integrin alpha-11
(Itga11), Thymus cell antigen 1 (Thy-1) and Epidermal growth factor receptor (Egfr)
were identified to be downregulated (Rayego-Mateos et al., 2013; Rege and Hagood
2006; Talior-Volodarsky et al. 2012).
Real time PCR was subsequently performed on separate RNA samples of Col1a2CreER(T);CCN2fl/fl and Col1a2-CreER(T);CCN2-/- SKPs in response to FBS to verify the
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differential expression of five genes: Mmp9, Timp3, Itga11, Thy-1 and Egfr. Consistent
with the microarray results, expression of Itga11, Egfr, Thy1 and Timp3 was significantly
decreased while expression of Mmp9 was significantly increased. (Figure 3.10)
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Table 3.1 Cluster analysis of differential gene expression in CCN2-/- vs CCN2fl/fl
SKPs in response to 24h 0.5% FBS treatment.
Gene Name
Extracellular Matrix
matrix metallopeptidase 9
matrix metallopeptidase 1a
connective tissue growth factor
tissue inhibitor of metalloproteinase 3
ADAMTS-like 1
collagen, type XII, alpha 1
aggrecan
Cytoskeleton
myosin, light chain 9
actin, alpha 2, smooth muscle
transgelin
actin, alpha 1, skeletal muscle
A kinase anchor protein 12
nexilin
Cell Adhesion
connective tissue growth factor
sorbin and SH3 domain containing 1
LIM and senescent cell antigen like domains 2
Multiple EGF-like-domains 10
thymus cell antigen 1, theta
contactin 1
dermatopontin
integrin alpha 11
Cell Motion
connective tissue growth factor
nerve growth factor receptor
epidermal growth factor receptor
integrin alpha 11

Gene Symbol

Fold Change

Mmp9
Mmp1a
Ctgf
Timp3
Adamtsl1
Col12a1
Acan

1.83033
1.77374
-3.03684
-1.77853
-1.69146
-1.42349
-1.41547

Myl9
Acta2
Tagln
Acta1
Akap12
Nexn

-2.38173
-1.64337
-1.52242
-1.52047
-1.51423
-1.41814

Ctgf
Sorbs1
Lims2
Megf10
Thy1
Cntn1
Dpt
Itga11

-3.03684
-1.96531
-1.68726
-1.59757
-1.58788
-1.50956
-1.45043
-1.41949

Ctgf
Ngfr
Egfr
Itga11

-3.03684
-1.50912
-1.42589
-1.41949
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Figure 3.10 Real time RT-PCR verification of CCN2-sensitive genes. SKPs were
isolated from Col1a2-CreER(T);CCN2fl/fl and Col1a2-CreER(T);CCN2-/- mice and
differentiated for 24 hours in 0.5% FBS. RNA was harvested and subjected to real time
RT-PCR analysis to compare genes identified by microarray as being differentially
expressed (Itga1, Egfr, Thy1, Mmp9 and Timp3). Error bars represent ± SEM. (*=
p<0.05, **=p<0.01; Student’s t-test; N=3).
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4

Discussion
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4.1

Summary of Results

Consistent with literature, I found that SKPs cultured from murine trunk skin
expressed the neural stem cell markers Sox2 and Nestin (Figure 3.1). By tracing the fate
of adult cells expressing Col1a2 and Sox2, I found that the vast majority of SKPs
cultured from murine trunk skin were derived from type I collagen-producing fibroblasts
and not Sox2-expressing hair follicle cells (Figure 3.2, Figure 3.3). Moreover, I found
that Col1a2-expressing fibroblasts could be cultured in monolayer and subsequently
induced to become Sox2+, Nestin+ SKPs when detached and reseeded in serum-free
medium containing bFGF (Figure 3.4, Figure 3.5). After being converted to SKPs, these
type I collagen-producing fibroblasts were capable of both neuronal and myofibroblastlike differentiation (Figure 3.6). To investigate the mechanisms behind myofibroblastic
differentiation, I first demonstrated that treatment of SKPs with 0.5% FBS for 24 hours
induced the expression of the myofibroblast marker α-SMA and the pro-fibrotic genes
CCN1 and CCN2 (Figure 3.7). I then showed that chemical inhibition of focal adhesion
kinase, Src-family kinases, and serum response factor all prevented myofibroblastic
differentiation along with the activation of CCN1 and CCN2 (Figure 3.8). To determine
if CCN2 played a direct role during differentiation, I used SKPs cultured from mice
conditionally deleted for CCN2 in Col1a2-expressing cells. Consistent with my finding
that SKPs were largely derived from Col1a2-expressing fibroblasts, SKPs from these
mice did not express CCN2 at either the mRNA or protein level (Figure 3.9). Moreover,
the knockdown of CCN2 resulted in a reduced ability of SKPs to differentiate into αSMA expressing cells (Figure 3.9), and was associated with changes in extracellular
matrix, cell adhesion and cell migration clusters of gene expression (Table 3.1, Figure

56

3.10). Taken together, my results support two major conclusions: (1) bFGF induces SKP
formation from dermal fibroblasts cultured in serum-free medium, and (2) CCN2 is a
mediator of the differentiation of SKPs into α-SMA-expressing myofibroblast-like cells.
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4.2

Research Significance and Future Studies

4.2.1 bFGF induces SKP formation from dermal fibroblasts cultured
in serum-free medium
SKPs from murine dorsal skin have traditionally been thought of as originating
from a hair follicle dermal papilla niche. Indeed, both SKPs and dermal papilla cells
exhibit neural crest properties, and microdissected dermal papilla cells form SKP-like
spheroids when grown in SKP growth medium (Biernaskie et al., 2009). However, the
data presented here provide strong evidence that the ability to form Sox2-expressing
SKPs in culture is not restricted to a population of endogenous Sox2-expressing precursor
cells. I have shown using lineage tracing techniques that murine cells that express Col1a2
at 3-4 weeks of age (adult dermal fibroblasts) comprise the majority of cells in SKP
spheroids whereas cells that express Sox2 (in the dermal papilla and dermal sheath) make
up a small minority. This suggests that adult dermal fibroblasts can be induced to express
neural stem cell markers and possess an inherent plasticity similar to the potential found
in the embryonic NIH/3T3 fibroblast cell line cultured as neurospheres (Wang et al.,
2011). My results also support and build upon the recent study by Krause et al. showing
that murine trunk SKPs are derived from an embryonic mesenchymal origin (Krause et
al., 2014). Here, I provide evidence that the mesenchymal-derived, SKP-forming cells in
the adult dermis are largely type I collagen-expressing cells: i.e. fibroblasts.
I have also shown that dermal fibroblasts cultured in monolayer can subsequently
be converted to proliferating, multipotent, Sox2+, Nestin+ SKPs by detachment and
reseeding in serum-free medium supplemented with bFGF alone. I found that the addition
of B-27 combined with bFGF increased initial spheroid size, but that B-27 alone was not
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sufficient to induce formation of spheroids. Furthermore, supplementation with EGF
alone resulted in the formation of small spheroids that did not grow. Taken together, this
data suggests that bFGF is the crucial factor in previously defined neurosphere media that
facilitates the formation and growth of SKP spheroids from fibroblasts. FGFs are
involved in diverse cellular processes including proliferation, differentiation, adhesion,
migration, survival and apoptosis (Turner and Grose, 2010). Endogenously, FGFs are a
large family of secreted molecules that are multifunctional and important for a wide
variety of developmental processes as well as tissue repair (Turner and Grose, 2010).
FGFs bind to their cognate tyrosine kinase receptors, the FGFRs, to activate signal
transduction through pathways including Ras/MAP kinase, Akt and phospholipase Cγ
(Goetz and Mohammadi., 2013). It has been shown that bFGF is an essential component
of embryonic stem cell culture medium that serves to maintain stem cells in a selfrenewing and undifferentiated state (Greber et al., 2011). In the context of this study,
whether bFGF acts directly or indirectly to induce changes in morphology and gene
expression associated with SKPs remains uncertain. Here, I have shown that bFGF allows
fibroblasts to survive and proliferate in suspension in serum-free conditions, and that
these cells are SKPs. It is thus possible that the simple alteration from cell-ECM/plastic
to cell-cell adhesions unmasks the neural precursor potential of fibroblasts. In addition to
promoting survival and proliferation in suspension conditions, bFGF may also play a role
in directly inducing changes in gene expression. Indeed, previous studies have shown that
bFGF is capable of inducing Sox2 expression in osteoblasts and Nestin expression in
glioma cells (Mansukhani et al., 2005; Chang et al., 2013).
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The question of why dermal fibroblasts possess the potential to become neural
precursor-like is intriguing, given that they are derived from a mesenchymal and not
neural crest origin (Krause et al., 2014). The answer may lie in whether the conversion of
fibroblasts to SKPs in culture recapitulates any in vivo phenomena. The formation of the
hair follicle dermal papilla could be such a process. Dermal papilla and dermal sheath
cells are recognized as specialized fibroblasts, and have been thought to be derived from
the dermal mesenchyme even though they paradoxically express neural crest markers
(Yang and Cotsarelis, 2010). Consistent with this notion, it has previously been
demonstrated by lineage tracing using a PDGFRα reporter targeting fibroblasts that the
DP and DS are derived in part from dermal fibroblasts both during development and
during adult hair follicle neogenesis (Collins et al., 2012). It thus seems likely that the
conversion of fibroblasts to SKPs in vitro and the conversion of fibroblasts to DP cells in
vivo share similar mechanisms, given that SKPs and DP cells are transcriptionally
similar. Interestingly, at least 4 FGFs and all four FGF receptors are expressed in the hair
follicle, with FGFR1 being localized specifically to the DP and DS (Kawano et al., 2005).
This raises the possibility that the FGF-mediated formation of SKPs from dermal
fibroblasts models the formation of the hair follicle DP.
The role of the hair follicle DP in hair development has been studied for decades
and is known to be important for hair follicle morphogenesis by functioning as a
signaling center for epidermal-mesenchymal cross-talk (Driskell et al., 2011).
Particularly, hair follicle formation is initiated when epidermal stem cells receive cues
from the underlying DP (Rendl et al., 2005). Early experiments by Oliver and coworkers
demonstrated that a combination of DP and epithelial cells implanted under the epidermis
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of an adult rat ear were capable of forming hair follicle-like structures (Oliver, 1970).
Furthermore, it was shown that the tissue origin of the implanted DP specified hair
follicle type regardless of the epithelial component (Ibrahim and Wright, 1982). Later
studies have identified Wnt, bone morphogenic protein (BMP) and FGF signaling
pathways as being important mediators of DP cell function during hair follicle cycling
(Greco et al., 2009; Kishimoto et al., 2000; Rendl et al., 2008). The hair inductive ability
of DP cells has significant implications for treatment of conditions involving hair loss. In
theory, being able to expand these cells would represent a method of generating a large
quantity of de novo hair follicles (Driskell et al., 2011). Early studies reported that
monolayer cultured DP cells were capable of hair follicle neogenesis after implantation,
but that this ability was lost upon passaging (Jahoda et al., 1984). Recent studies have
shown that culturing DP cells in medium containing bFGF results in the formation of
spheroids that are capable of hair follicle induction upon repeated passaging, and that the
spheroids partially model the intact DP (Osada et al., 2007; Higgins et al., 2010). These
findings beg the question of whether SKPs formed from fibroblasts are also capable of
hair follicle induction, given that they are induced to express DP markers. Since dermal
fibroblasts represent a much more abundant and easily accessible source of cells
compared to isolated DP cells, future investigations are warranted to determine if adult
fibroblasts can be cultured, expanded, converted to SKPs, and subsequently implanted to
form hair follicles.
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4.2.2 CCN2 is a mediator of the differentiation of SKPs into α-SMAexpressing myofibroblast-like cells
Several lineage tracing studies have been performed in recent years to elucidate the
origins of myofibroblasts in fibrotic diseases, resulting in various populations of
progenitor cells being identified as key contributors to the myofibroblast population in
models of kidney, liver, lung and skin fibrosis (Kramann et al., 2015). Our group has
previously identified Sox2-expressing cells located in the hair follicle dermal papilla
(DP) as a migratory precursor cell population that contributes to bleomycin-induced skin
fibrosis in a CCN2-dependent manner (Liu et al., 2013). Given that SKPs and DP cells
are transcriptionally similar, we tested the ability of SKPs to differentiate into a-SMAexpressing myofibroblast-like cells. Here I have shown that the serum-induced
myofibroblastic differentiation of SKP spheroids is dependent on FAK, Src-family kinase
and SRF signaling pathways, that those pathways activate CCN1/CCN2, and that the
deletion of CCN2 in SKPs impairs myofibroblastic differentiation.
My finding that chemical inhibition of FAK, Src-family kinase or SRF pathways
prevented serum-induced myofibroblastic differentiation of SKPs and activation of
CCN2 mirrors previous studies showing that these inhibitors prevent TGFβ-induced
fibroblast-to-myofibroblast differentiation (Shi-wen et al., 2012; Haak et al., 2014). The
CCN2 promoter contains a CArG-like box that is inducible by SRF, and it has been
shown that overexpression of SRF results in significantly increased CCN2 protein
synthesis (Muehlich, 2007). These results thus support the notion that FAK/Src and SRF
signaling is important for fibrosis. However, it remains to be elucidated whether FAK/Src
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exerts its pro-fibrotic effect directly through SRF, or if it also acts through SRFindependent pathways.
In addition, I also found that CCN1 (Cyr61) was induced during SKP differentiation
and suppressed by FAK/Src and SRF inhibition. CCN1 is a matricellular protein that is
structurally similar to CCN2 and like CCN2 is involved in a wide range of cellular and
biological processes. CCN1 has been studied primarily for its critical role during
angiogenesis; however, its role in fibrogenesis is currently unclear. Unpublished
preliminary results in our lab suggest that CCN1 acts synergistically with CCN2 during
fibrosis by regulating collagen crosslinking. Further studies are warranted to determine if
CCN1 is involved in myofibroblast differentiation, and to determine whether targeting
CCN1 and CCN2 simultaneously in potential anti-fibrotic treatments may be more
effective than targeting either protein alone.
My finding that SKPs deleted for CCN2 exhibit impaired myofibroblastic
differentiation suggests that CCN2 plays a direct role in the activation of contractile
machinery in neural crest-like precursor cells, and is consistent with the notion that
CCN2 primes cells to be more susceptible to fibrotic stimuli (Tong et al., 2009). These
results are in agreement with previous studies implicating the involvement of CCN2 in
the myofibroblastic transdifferentiation of precursor cells in fibrosis. In a model of skin
fibrosis, it was shown that CCN2 expression is required by DP cells for their recruitment
and differentiation into myofibroblasts within the fibrotic lesion (Liu et al., 2013). In a
model of myocardial fibrosis, it was demonstrated that CCN2 mediates the accumulation
of bone-marrow derived fibrocytes and enhances their differentiation into a myofibroblast
phenotype responsible for ECM deposition (Rosin et al., 2013). In a model of liver
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fibrosis, it was shown that silencing CCN2 inhibits the activation of pericyte-like hepatic
stellate cells to express α-SMA (Li et al., 2010). Interestingly, it has even been shown
that CCN2 is required for the transdifferentiation of epithelial cells into α-SMAexpressing myofibroblast-like cells (Sonnylal et al., 2013). Taken together, although the
precursor populations that contribute to fibrosis in different organs are likely
heterogeneous, CCN2 expression appears to be commonly associated with the
dysregulation of precursor cells during the fibrotic response. Thus, targeting CCN2
directly may represent an effective anti-fibrotic treatment that avoids altering potential
pleiotropic effects of more upstream mediators. Indeed, a CCN2 neutralizing antibody
currently in clinical development has been shown to be effective in preventing and
reversing lung fibrosis (Lipson et al., 2012).
The gene expression profiling results here provide an interesting insight on how
CCN2 may exert its effects. Notably, several genes associated with matrix degradation
were differentially expressed in CCN2-/- cells, consistent with the idea that CCN2 is profibrotic and normally suppresses matrix breakdown (Brigstock, 2009). Furthermore, fives
genes in the cytoskeleton cluster found to be downregulated in CCN2-/- cells
corresponded to genes encoding contractile proteins, suggesting that CCN2 activates
multiple genes associated with the myofibroblast phenotype. Altered expression of
several genes associated with cell adhesion and migration were also identified, which
may represent downstream targets of CCN2. I used real time RT-PCR to verify the
differential expression of five genes of interest, Integrin alpha-11 (Itga11), Epidermal
growth factor receptor (Egfr), Thy-1, Matrix metallopeptidase 9 (Mmp9) and
Metalloproteinase inhibitor 3 (Timp3). Itga11 is a major collagen receptor on fibroblastic
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cells and has been shown to control myofibroblast differentiation in multiple fibroblast
types in vitro (Talior-Volodarsky et al. 2012). Egfr has been identified as a novel ligand
for CCN2 (Rayego-Mateos et al., 2013), and its loss has been shown to result in
resistance to TGF-β induced myofibroblast differentiation (Midgley et al., 2013). Thy-1
is a cell surface protein known to be a marker of fibroblasts and has been shown to be a
functional signaling protein in myofibroblasts that acts downstream of FAK/Src (Rege
and Hagood 2006). Mmp9 is a matrix metalloproteinase involved in the breakdown of
extracellular matrix components, and has been shown to have anti-fibrotic effects by
cleaving excessive matrix deposition (Cabrera et al., 2007). Its upregulation in CCN2-/cells is consistent with previous findings that a notochord-specific CCN2 knockout
increases Mmp9 mediated Aggrecan degradation (Bedore et al., 2013). In conjunction,
Timp3, an endogenous inhibitor of metalloproteinases, was verified to be significantly
downregulated. Taken together, CCN2 likely mediates myofibroblast differentiation via
altered adhesive signaling and extracellular matrix interactions.
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4.3

Conclusions

My results support a number of conclusions (summarized in Figure 4.1). First,
although SKPs express Sox2, SKPs are largely derived from type I collagen-producing
adult dermal fibroblasts and not an endogenous Sox2-expressing precursor population.
Second, adult dermal fibroblasts possess inherent plasticity to become neural crest
precursor-like when cultured in serum free medium containing bFGF. Third, bulk
cultured SKPs can effectively be targeted for genetic knockout using the Col1a2
promoter. Fourth, the myofibroblastic differentiation of SKPs is regulated by the
FAK/Src and SRF-induced activation of CCN2. Fifth, CCN2 promotes the expression of
contractile genes and is associated with adhesive signaling and extracellular matrix
interactions. Overall, my results support the notion that fibroblasts possess a high degree
of inherent plasticity, and that CCN2 is a mediator of progenitor cell dysregulation in
fibrosis.
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Figure 4.1 Schematic overview for the formation and differentiation of fibroblastderived SKPs. Col1a2-expressing dermal fibroblasts (isolated either directly from tissue
or from trypsinized monolayer) are induced to become SKP spheroids when cultured in
serum-free medium supplemented with bFGF. Treatment of floating SKP spheroids with
serum induces adhesion, radial spreading and proliferation. Activation of FAK/Src and
SRF result in the expression of CCN2, which contributes to myofibroblastic
differentiation through the regulation of ECM, adhesive and cytoskeletal genes. Through
a pathway yet to be elucidated, NGF induces SKP differentiation into BIII-tubulinexpressing neuronal cells.
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Supplementary Content
Supplemental Table 1. Full list of differentially expressed genes in CCN2-/- vs
CCN2fl/fl SKPs in response to 24h 0.5% FBS treatment (Fold change >|1.4|, p<0.05,
N=2).

Gene Name

Gene Symbol

Fold Change

connective tissue growth factor
G protein-coupled receptor 133
myosin, light polypeptide 9, regulatory
adenylate cyclase activating polypeptide 1 receptor 1
cytochrome P450, family 4, subfamily a, polypeptide
12B
deleted in bladder cancer 1 (human)
sorbin and SH3 domain containing 1
granzyme D
carbonic anhydrase 2
mesenchyme homeobox 1
fibrinogen-like protein 2
growth differentiation factor 6
growth arrest and DNA-damage-inducible 45 gamma
caspase 1
CAP, adenylate cyclase-associated protein, 2
ADAMTS-like 1
LIM and senescent cell antigen like domains 2
keratin 20
actin, alpha 2, smooth muscle, aorta
netrin 4
granzyme C
suppressor of cytokine signaling 2
leucine rich repeat containing 7
programmed cell death 4
multiple EGF-like-domains 10
chemokine (C-X-C motif) ligand 14
thymus cell antigen 1, theta
olfactory receptor 508
cytidine monophospho-N-acetylneuraminic acid
hydroxylase
angiopoietin-like 7
protease, serine, 23

Ctgf
Gpr133
Myl9
Adcyap1r1

-3.03684
-2.59341
-2.38173
-2.32733

Cyp4a12b

-2.2033

Dbc1
Sorbs1
Gzmd
Car2
Meox1
Fgl2
Gdf6
Gadd45g
Casp1
Cap2
Adamtsl1
Lims2
Krt20
Acta2
Ntn4
Gzmc
Socs2
Lrrc7
Pdcd4
Megf10
Cxcl14
Thy1
Olfr508

-1.97189
-1.96531
-1.94857
-1.94609
-1.90741
-1.72611
-1.72287
-1.71392
-1.70599
-1.70117
-1.69146
-1.68726
-1.64377
-1.64337
-1.63965
-1.6267
-1.619
-1.61398
-1.60282
-1.59757
-1.5954
-1.58788
-1.57938

Cmah

-1.56904

Angptl7
Prss23

-1.54256
-1.54228
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guanylate cyclase 1, soluble, alpha 2
Kruppel-like factor 8
transgelin
actin, alpha 1, skeletal muscle
sodium channel, voltage-gated, type VII, alpha
thyrotroph embryonic factor
pregnancy-associated plasma protein A
A kinase (PRKA) anchor protein (gravin) 12
contactin 1
nerve growth factor receptor (TNFR superfamily,
member 16)
neuropilin (NRP) and tolloid (TLL)-like 1
family with sequence similarity 115, member E
tryptase beta 2
gasdermin A
ATP-binding cassette, sub-family D (ALD), member 2
microtubule-associated protein 2
zinc finger protein 804A
dermatopontin
UDP-N-acetyl-alpha-D-galactosamine:polypeptide Nacetylgalactos
grancalcin
sialic acid binding Ig-like lectin G
serine (or cysteine) peptidase inhibitor, clade A,
member
glycogen synthase kinase 3 beta
epidermal growth factor receptor
collagen, type XII, alpha 1
procollagen-proline, 2-oxoglutarate 4-dioxygenase
potassium voltage-gated channel, Shal-related family,
member 3
chemokine (C-C motif) receptor 2
integrin alpha 11
nexilin
aggrecan
adducin 2 (beta)
NK3 homeobox 2
FBJ osteosarcoma oncogene
beta galactoside alpha 2,6 sialyltransferase 1
serine (or cysteine) peptidase inhibitor, clade B,
member 8
glutathione reductase
microRNA 1931
SH2 domain containing 5

Gucy1a2
Klf8
Tagln
Acta1
Scn7a
Tef
Pappa
Akap12
Cntn1

-1.53184
-1.5313
-1.52242
-1.52047
-1.51807
-1.51688
-1.51427
-1.51423
-1.50956

Ngfr

-1.50912

Neto1
Fam115e
Tpsb2
Gsdma
Abcd2
Mtap2
Zfp804a
Dpt

-1.5051
-1.50396
-1.48961
-1.48833
-1.47299
-1.46933
-1.46281
-1.45043

Galntl4

-1.43733

Gca
Siglecg

-1.43729
-1.43559

Serpina3f

-1.43511

Gsk3b
Egfr
Col12a1
P4ha3

-1.4341
-1.42589
-1.42349
-1.42252

Kcnd3

-1.42012

Ccr2
Itga11
Nexn
Acan
Add2
Nkx3-2
Fos
St6gal1

-1.41957
-1.41949
-1.41814
-1.41547
-1.40559
-1.40425
-1.40291
1.40081

Serpinb8

1.40261

Gsr
Mir1931
Sh2d5

1.40276
1.40561
1.40666
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neuronal pentraxin 1
CD40 antigen
sphingomyelin phosphodiesterase, acid-like 3B
NADH dehydrogenase subunit 6
DnaJ (Hsp40) homolog, subfamily B, member 14
inhibitor of kappaB kinase epsilon
very low density lipoprotein receptor
R-spondin family, member 4
dCTP pyrophosphatase 1
N-deacetylase
dachshund 1 (Drosophila)
interleukin 6
neuron specific gene family member 1
C1q and tumor necrosis factor related protein 7
ATP-binding cassette, sub-family B (MDR
vomeronasal 1, receptor 49
hephaestin
monooxygenase, DBH-like 1
LanC lantibiotic synthetase component C-like 3
stanniocalcin 1
uridine phosphorylase 1
ring finger protein 183
sialophorin, pseudogene
olfactory receptor 1106
microRNA 542
hepatitis A virus cellular receptor 2
membrane-spanning 4-domains, subfamily A, member
4B
integrin alpha 2
phosphatidylinositol 3-kinase, catalytic, beta
polypeptide
G protein-coupled receptor 83
processing of precursor 7, ribonuclease P family
histone cluster 2, H2bb
a disintegrin and metallopeptidase domain 4
serum/glucocorticoid regulated kinase 3
nucleoporin 62 C-terminal like
family with sequence similarity 69, member A
rhomboid 5 homolog 2
alpha 1,4-galactosyltransferase
phosphofructokinase, liver, B-type
leprecan-like 1
selectin, endothelial cell

Nptx1
Cd40
Smpdl3b
ND6
Dnajb14
Ikbke
Vldlr
Rspo4
Dctpp1
Ndst3
Dach1
Il6
Nsg1
C1qtnf7
Abcb1b
Vmn1r49
Heph
Moxd1
Lancl3
Stc1
Upp1
Rnf183
Spn-ps
Olfr1106
Mir542
Havcr2

1.40714
1.40782
1.40808
1.41157
1.41384
1.41435
1.41583
1.4179
1.4207
1.42107
1.42518
1.42645
1.42668
1.42827
1.429
1.43768
1.44032
1.44101
1.44567
1.44612
1.45219
1.45498
1.46061
1.4607
1.46371
1.47387

Ms4a4b

1.47755

Itga2

1.47766

Pik3cb

1.47773

Gpr83
Pop7
Hist2h2bb
Adam4
Sgk3
Nup62cl
Fam69a
Rhbdf2
A4galt
Pfkl
Leprel1
Sele

1.48097
1.48696
1.48878
1.49567
1.5069
1.50967
1.51222
1.51386
1.52659
1.5281
1.53976
1.54627
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retinoid X receptor gamma
protease, serine, 35
interleukin 23 receptor
olfactory receptor 127
natriuretic peptide type B
chitinase 3-like 1
lymphocyte antigen 75
neuropilin 2
olfactory receptor 1254
Eph receptor A2
catenin (cadherin associated protein), alpha-like 1
microRNA 1950
schlafen 3
polymerase (RNA) II (DNA directed) polypeptide K
histone cluster 2, H3b
zinc finger protein 704
transmembrane protein 22
aquaporin 8
forkhead box C2
histone cluster 2, H3c2
transmembrane protein 132D
transmembrane protein 26
solute carrier family 38, member 1
matrix metallopeptidase 1a (interstitial collagenase)
matrix metallopeptidase 9
Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6
MAS-related GPR, member A9
dehydrogenase/reductase (SDR family) member 9
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase,
pol
solute carrier organic anion transporter family,
member 4a1
protamine 1
complement component 3
fatty acid binding protein 4, adipocyte

Rxrg
Prss35
Il23r
Olfr127
Nppb
Chi3l1
Ly75
Nrp2
Olfr1254
Epha2
Ctnnal1
Mir1950
Slfn3
Polr2k
Hist2h3b
Zfp704
Tmem22
Aqp8
Foxc2
Hist2h3c2
Tmem132d
Tmem26
Slc38a1
Mmp1a
Mmp9
Arhgef6
Mrgpra9
Dhrs9

1.56503
1.5675
1.57132
1.57277
1.58215
1.58554
1.58564
1.58913
1.60115
1.60637
1.61247
1.61265
1.61404
1.63419
1.63421
1.64953
1.65184
1.65994
1.66963
1.67196
1.67454
1.67611
1.70908
1.77374
1.83033
1.86586
1.91651
1.9195

B3galt2

2.06128

Slco4a1

2.06643

Prm1
C3
Fabp4

2.09748
2.33929
2.56557
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